COMPANY
Avotres
Timeline
- Trial start Phase 1/Phase 2: Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03895996 | Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes | Phase 1/Phase 2 | Completed | Jun 20, 2019 | May 17, 2022 (actual) |